Schedule 13D ownership disclosure

Juno Therapeutics, Inc.

Security class unavailable · CUSIP: 48205A109

Event date: 2015-06-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
28.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-15-235205
Form type
SC 13D/A
Filer
BRATTON DOUGLAS K
CIK
CIK 1281933
Filed
Jun 25, 2015
Reporting period
Jun 25, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub